Could a cancer drug ease sickle cell pain? early trial launches
Disease control
Recruiting now
This early-stage trial is testing the safety of a drug called panobinostat in 18 adults with sickle cell disease. The drug aims to boost fetal hemoglobin and reduce inflammation, which may help control the disease. Participants take capsules three times a week for 12 weeks, and r…
Phase: PHASE1 • Sponsor: Abdullah Kutlar • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC